Moreover, we recently demonstrated that ADAR2 deaminase activity is sufficient to inhibit glioblastoma proliferation and tumor growth, as it modulates the CDC14B/Skp2/p21/p27 pathway in adult glioblastoma cell lines and this was further confirmed in different grades of pediatric glioma [21]. Here, CDKN1B is linked to glioblastoma.